Back to newsBlossomhill Therapeutics Inc <BLSM.O>: Guggenheim raises target price to $40 from $30BBLSM•2026-09-21Related NewsSGlobal Markets-Tech leads shares higher in Asia as oil slips
BLSM•BLSM•BLSM•BLSM•
